HRS Aluglaze SME
smeOngoing
GMP
₹20
smeOngoing
HRS Aluglaze SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹20
(+20.83%) Est. Gain
Investment Timeline
✓
IPO Open
11 Dec 2025
🔒
IPO Close
15 Dec 2025
🎲
Allotment
16 Dec 2025
🔔
Listing
18 Dec 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
55/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
✅ Good subscription levels indicate positive market sentiment
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
📈 Moderate listing gains possible (5-12%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹94.0 - ₹96.0
📦Lot Size
1200 shares
💰Issue Size
₹48.28 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of HRS Aluglaze SME?
As of today, the Grey Market Premium (GMP) for HRS Aluglaze SME is ₹20, which is approximately (+20.83%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for HRS Aluglaze SME?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 55/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for HRS Aluglaze SME be announced?
The allotment status for HRS Aluglaze SME is expected to be finalized on 16 Dec 2025. Investors can check their status on the registrar's website.
What is the listing date for HRS Aluglaze SME?
Shares of HRS Aluglaze SME are proposed to be listed on stock exchanges on 18 Dec 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.